posted on 2017-04-27, 00:00authored byTingbin Zhang, Weisheng Guo, Chunqiu Zhang, Jing Yu, Jing Xu, Shuyi Li, Jian-Hua Tian, Paul C. Wang, Jin-Feng Xing, Xing-Jie Liang
Viruses
have evolved to be outstandingly efficient at gene delivery, but their
use as vectors is limited by safety risks. Inspired by the structure
of viruses, we constructed a virus-mimicking vector (denoted as TR4@siRNA@Tf
NCs) with virus-like architecture and infection properties. Composed
of a hydrophilic peptide, an aggregation-induced emission (AIE) luminogen,
and a lipophilic tail, TR4 imitates the viral capsid and endows the
vector with AIE properties as well as efficient siRNA compaction.
The outer glycoprotein transferrin (Tf) mimics the viral envelope
protein and endows the vector with reduced cytotoxicity as well as
enhanced targeting capability. Because of the strong interaction between
Tf and transferrin receptors on the cell surface, the Tf coating can
accelerate the intracellular release of siRNA into the cytosol. Tf
and TR4 are eventually cycled back to the cell membrane. Our results
confirmed that the constructed siRNA@TR4@Tf NCs show a high siRNA
silencing efficiency of 85% with significantly reduced cytotoxicity.
These NCs have comparable transfection ability to natural viruses
while avoiding the toxicity issues associated with typical nonviral
vectors. Therefore, this proposed virus-like siRNA vector, which integrates
the advantages of both viral and nonviral vectors, should find many
potential applications in gene therapy.